Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

60 Degrees Pharmaceuticals, Inc.

NASDAQ: SXTP · Life Sciences · 6 alerts · CIK 1946563

Share price
$0.4938Close, Nov 16
Market cap
$2.21M
Shares outstanding
4.48MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All 60 Degrees Pharmaceuticals, Inc. filings on SEC EDGAR ↗

8:06 AM ET 8-K
Clinical Trial Data

60 Degrees Pharmaceuticals Clinical Trial Data

60 Degrees Pharmaceuticals announced positive clinical and molecular results from the first five patients in its expanded access study of tafenoquine-containing regimens for relapsing babesiosis. All five patients (100%) reported significant clinical improvement and tested negative for Babesia on conventional PCR tests, supporting the potential efficacy of the combination therapy in immunosuppressed patients.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.